AJR Am J Roentgenol
- PARK C, Lee BC, Jeong WG, Park WJ, et al
Coronary Artery Calcification on Low-Dose Lung Cancer Screening CT in South
Korea: Visual and Artificial Intelligence-Based Assessment and Association With
Cardiovascular Events.
AJR Am J Roentgenol. 2024 Mar 6. doi: 10.2214/AJR.24.30852.
- HARDIE RC, Trout AT, Dillman JR, Narayanan BN, et al
Performance Analysis in Children of Traditional and Deep-Learning CT Lung Nodule
Computer-Aided Detection Systems Trained on Adults.
AJR Am J Roentgenol. 2023 Nov 22. doi: 10.2214/AJR.23.30345.
- PARK J, Lee JH, Hong W, Hwang EJ, et al
Usual Interstitial Pneumonia: Associations With Complications After Percutaneous
Transthoracic Needle Lung Biopsy.
AJR Am J Roentgenol. 2024;222:e2329938.
Am J Ind Med
- MARKOWITZ S, Ringen K, Dement JM, Straif K, et al
Occupational lung cancer screening: A Collegium Ramazzini statement.
Am J Ind Med. 2024 Mar 5. doi: 10.1002/ajim.23572.
Ann Surg Oncol
- SARVESTANI AL, Lambdin J, Hu M, Cabanillas M, et al
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers.
Ann Surg Oncol. 2024;31:2202-2203.
- CHATTERJEE A, Kusamura S, Baratti D, Guaglio M, et al
ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant
Peritoneal Mesothelioma treated with CRS-HIPEC.
Ann Surg Oncol. 2024;31:2511-2512.
- SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related
Markers in Patients with Adenocarcinoma of the Lung.
Ann Surg Oncol. 2024;31:2521-2522.
Anticancer Res
- YOSHIDA C, Kadota K, Ibuki E, Ishikawa R, et al
Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic
Factor in Stage I Lung Adenocarcinoma.
Anticancer Res. 2024;44:1289-1297.
BMC Cancer
- WANG Y, Ouyang S, Liu M, Si Q, et al
Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its
tumor-promoting potential in lung cancer.
BMC Cancer. 2024;24:283.
- ZHOU J, Yu B, Guo P, Wang S, et al
The insufficiency of CT examination in early detection of central lung squamous
cell carcinoma and squamous epithelial precancerous lesions.
BMC Cancer. 2024;24:299.
- CHENG M, Shao Y, Li L, Jiang M, et al
Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung
cancer: a systematic review.
BMC Cancer. 2024;24:312.
- WU C, Cao B, He G, Li Y, et al
Stereotactic ablative brachytherapy versus percutaneous microwave ablation for
early-stage non-small cell lung cancer: a multicenter retrospective study.
BMC Cancer. 2024;24:304.
- LIU J, Bian T, She B, Liu L, et al
Evaluating the comprehensive diagnosis efficiency of lung cancer, including
measurement of SHOX2 and RASSF1A gene methylation.
BMC Cancer. 2024;24:282.
Br J Cancer
- FU X, Liu S, Cao D, Li C, et al
Med23 deficiency reprograms the tumor microenvironment to promote lung
tumorigenesis.
Br J Cancer. 2024;130:716-727.
- BLANCO E, Silva-Pilipich N, Bocanegra A, Chocarro L, et al
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise
tumours to PD-1/PD-L1 blockade strategies.
Br J Cancer. 2024;130:869-879.
Cancer Lett
- ZHANG E, Sun Q, Zhang C, Ma H, et al
Comprehensive functional interrogation of susceptibility loci in GWASs identified
KIAA0391 as a novel oncogenic driver via regulating pyroptosis in NSCLC.
Cancer Lett. 2024;585:216646.
Cancer Res
- WANG H, Zhang Y, Tian Y, Yang W, et al
DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung
Squamous Cell Carcinoma Malignancy and Chemoresistance.
Cancer Res. 2024;84:688-702.
Cancer Sci
- ISHIDA M, Iwasaku M, Doi T, Ishikawa T, et al
Nationwide data from comprehensive genomic profiling assays for detecting driver
oncogenes in non-small cell lung cancer.
Cancer Sci. 2024 Mar 7. doi: 10.1111/cas.16130.
- WANG S, Wang J, Gong W, Zhang F, et al
ILT4 facilitates angiogenesis in non-small cell lung cancer.
Cancer Sci. 2024 Mar 3. doi: 10.1111/cas.16126.
Clin Lung Cancer
- PONVILAWAN B, Mahadevia H, Qasim H, Sharma P, et al
Brief Report: Evaluating the Impact of Perioperative Immune Checkpoint Inhibitor
in the Treatment of Patients with Resectable Non-Small Cell Lung Cancer: A
Systematic Review and Meta-Analysis.
Clin Lung Cancer. 2024 Feb 15:S1525-7304(24)00014.
- TSUBOKAWA N, Mimae T, Mimura T, Kamigaichi A, et al
Clinical Significance of Preserving Pulmonary Function After Lung Resection in
Early-Stage Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Jan 26:S1525-7304(24)00005.
- FIROZ WA, Sen F, Kiuru M, Huang V, et al
A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation
Developing Unusual Skin Metastasis.
Clin Lung Cancer. 2024 Jan 30:S1525-7304(24)00011.
Clin Nucl Med
- LI X, Tian B, Bai X
FDG PET/CT Findings of a Small Cell Carcinoma of the Lung Presented as Diffuse
Dermatomyositis.
Clin Nucl Med. 2024;49:379-380.
- KALANTARI F, Schweighofer-Zwink G, Rendl G, Pirich C, et al
18F-FDG and 68Ga-PSMA PET/CT in Paratesticular Mesothelioma.
Clin Nucl Med. 2024;49:332.
- TIAN T, Xie H, Huang M
Epithelial Malignant Pleural Mesothelioma Mimics Lymphoma on 18F-FDG PET/MRI: A
Case Report.
Clin Nucl Med. 2024 Feb 7. doi: 10.1097/RLU.0000000000005095.
- SINGH P, Parida GK, Singhal T, Gupta J, et al
Incidental Detection of Myocardial Ischemia on Whole-Body PET/CT in a Patient
With Carcinoma Lung.
Clin Nucl Med. 2024 Feb 6. doi: 10.1097/RLU.0000000000005082.
- BOURBONNE V, Dissaux B, Seizeur R, Nguyen J, et al
Mismatch Between Brain MRIs and 18F-DOPA PET/CT: Impact on the Management of a
Long Survivor With EGFR-Mutated Lung Adenocarcinoma.
Clin Nucl Med. 2024 Feb 12. doi: 10.1097/RLU.0000000000005058.
- JALEEL J, Damle NA, Khurana A, Joshi M, et al
Pulmonary Mucoepidermoid Carcinoma Mimicking Carcinoid Lung on 18F-FDG and
68Ga-DOTANOC PET/CT.
Clin Nucl Med. 2024 Feb 2. doi: 10.1097/RLU.0000000000005107.
Eur J Cardiothorac Surg
- SINGH A, Mazzola E, Xie Y, Marshall MB, et al
Lung cancer outcomes in the elderly: Potential disparity in screening.
Eur J Cardiothorac Surg. 2024 Mar 5:ezae080. doi: 10.1093.
- BONGIOLATTI S, Gonfiotti A, Salvicchi A, Voltolini L, et al
The role of minimally invasive surgery on cT4 tumours: still many unanswered
question.
Eur J Cardiothorac Surg. 2024;65:ezae049.
Eur Respir J
- YOON HY, Kim SY, Song JW
Association Between High Levels of Nitrogen Dioxide and Increased Cumulative
Incidence of Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
Eur Respir J. 2024 Mar 7:2301181. doi: 10.1183/13993003.01181-2023.
Int J Radiat Oncol Biol Phys
- YAN W, Ren Z, Chen X, Zhang R, et al
Potential role of lymphocyte CD44 in determining treatment selection between
stereotactic body radiotherapy and surgery for early-stage non-small-cell lung
cancer.
Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
J Cancer Res Clin Oncol
- MA M, Luo M, Liu Q, Zhong D, et al
Influence of abdominal fat distribution and inflammatory status on post-operative
prognosis in non-small cell lung cancer patients: a retrospective cohort study.
J Cancer Res Clin Oncol. 2024;150:111.
J Clin Invest
- CHEN Z, Vallega KA, Wang D, Quan Z, et al
DNA topoisomerase II inhibition potentiates osimertinib's therapeutic efficacy in
EGFR-mutant non-small cell lung cancer models.
J Clin Invest. 2024 Mar 7:e172716. doi: 10.1172/JCI172716.
J Nucl Med
- CUZZANI G, Fortunati E, Zanoni L, Nanni C, et al
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on
[(68)Ga]Ga-FAPI PET/CT.
J Nucl Med. 2024 Mar 7:jnumed.123.267155. doi: 10.2967/jnumed.123.267155.
- HOVHANNISYAN-BAGHDASARIAN N, Luporsi M, Captier N, Nioche C, et al
Promising Candidate Prognostic Biomarkers in [(18)F]FDG PET Images: Evaluation in
Independent Cohorts of Non-Small Cell Lung Cancer Patients.
J Nucl Med. 2024 Mar 7:jnumed.123.266331. doi: 10.2967/jnumed.123.266331.
- LI C, Chen Q, Tian Y, Chen J, et al
(68)Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph
Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
J Nucl Med. 2024 Mar 7:jnumed.123.266806. doi: 10.2967/jnumed.123.266806.
J Surg Oncol
- SAIKIA J, Malik PS, Kumar S, Jain D, et al
Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic
biomarker among surgically treated Stage I-III a nonsmall cell lung cancer
(NSCLC)? A pilot study.
J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27610.
J Thorac Cardiovasc Surg
- KRISTENSON K, Hedman K
Percent predicted peak oxygen uptake is superior to weight-indexed peak oxygen
uptake in risk stratification before lung cancer lobectomy.
J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00187.
J Thorac Oncol
- WERNER RS, Curioni-Fontecedro A, Mauti LA, Addeo A, et al
Lung Cancer in Switzerland.
J Thorac Oncol. 2024;19:385-394.
- TEN HAAF K
Considerations for Enhancing Lung Cancer Risk Prediction and Screening in Asian
Populations.
J Thorac Oncol. 2024;19:373-375.
- RAMI-PORTA R, Nishimura KK, Giroux DJ, Detterbeck F, et al
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage
Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung
Cancer.
J Thorac Oncol. 2024 Mar 4:S1556-0864(24)00079.
- KIM BG, Yoon S, Lee SY, Sohn JW, et al
How Does Rheumatoid Arthritis Increase the Risk of Lung Cancer?
J Thorac Oncol. 2024;19:509-510.
JAMA Oncol
- TSUKITA Y, Tozuka T, Kushiro K, Hosokawa S, et al
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell
Lung Cancer.
JAMA Oncol. 2024 Mar 7. doi: 10.1001/jamaoncol.2023.6277.
- PALMA DA, Bahig H, Hope A, Harrow S, et al
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and
Interstitial Lung Disease: A Nonrandomized Clinical Trial.
JAMA Oncol. 2024 Mar 7. doi: 10.1001/jamaoncol.2023.7269.
Lancet
- EDERHY S, Cadranel J, Granger C, Hammoudi N, et al
Investigation of endocarditis finds advanced lung adenocarcinoma: both resolve
after tyrosine kinase inhibitor treatment.
Lancet. 2024;403:860-861.
Lung Cancer
- CONNOR WELLS J, Mullin MM, Ho C, Melosky B, et al
Outcomes of patients with advanced epithelial growth factor receptor mutant lung
cancer treated with first-line osimertinib who would not have met the eligibility
criteria for the FLAURA clinical trial.
Lung Cancer. 2024;190:107529.
- SAEKI Y, Maki N, Nemoto T, Inada K, et al
Lung cancer detection in perioperative patients' exhaled breath with
nanomechanical sensor array.
Lung Cancer. 2024;190:107514.
- GOULIAEV A, Ali F, Jakobsen E, Dalton SO, et al
The Danish lung cancer registry: A nationwide validation study.
Lung Cancer. 2024;190:107527.
- CHUL CHO B, Han JY, Hyeong Lee K, Lee YG, et al
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced
non-small cell lung cancer: Long-term follow-up results from LASER201.
Lung Cancer. 2024;190:107509.
- BAPTISTE OUDART J, Garinet S, Leger C, Barlesi F, et al
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage
non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT
TASTE trial.
Lung Cancer. 2024;190:107508.
- KRAUS KM, Oreshko M, Schnabel JA, Bernhardt D, et al
Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and
immune checkpoint inhibition: The relevance of fractionation.
Lung Cancer. 2024;189:107507.
- KAIRA K, Imai H, Kagamu H
Drastic response of sunitinib after failure of Lenvatinib in patients with
previously treated thymic carcinoma.
Lung Cancer. 2024;189:107501.
- ZHOU P, Fu Y, Tang Y, Jiang L, et al
Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and
prognostic analysis of 35 cases and immunotherapy efficacy.
Lung Cancer. 2024;189:107471.
- MOLINA TJ, Roden AC, Szolkowska M, Shimizu S, et al
International reproducibility study of thymic epithelial tumors staging: pT stage
is an issue. proposals for improvement. A RYTHMIC/ITMIG study.
Lung Cancer. 2024;189:107479.
- KLOKER LD, Sidiras M, Flaadt T, Brecht IB, et al
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival,
therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Lung Cancer. 2024;189:107496.
- FITZGERALD SM
Resolving asbestos and ultrafine particulate definitions with carcinogenicity.
Lung Cancer. 2024;189:107478.
- STARES M, Doyle E, Chapple S, Raynes G, et al
Prognostic value of the Scottish Inflammatory prognostic Score in patients with
NSCLC expressing PD-L1 >/= 50 % progressing on first-line pembrolizumab.
Lung Cancer. 2024;189:107497.
- CHEN Y, Chen H, Yu R, Zeng X, et al
Pulmonary blastoma is successfully treated with immunotherapy and targeted
therapy.
Lung Cancer. 2024;189:107476.
Mol Cancer Ther
- MCCRURY M, Swafford K, Shuttleworth SL, Mehdi SH, et al
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of
Oncogenic Pathways in Lymphoma.
Mol Cancer Ther. 2024;23:316-329.
Oncogene
- GUO J, Kim D, Gao J, Kurtyka C, et al
Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines
chemosensitivity in non-small cell lung cancer.
Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02993.
- XU X, Qiu S, Zeng B, Huang Y, et al
N(6)-methyladenosine demethyltransferase FTO mediated m(6)A modification of
estrogen receptor alpha in non-small cell lung cancer tumorigenesis.
Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02992.
Oncologist
- XU Y, Wen N, Haddad RI, Sonis ST, et al
Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer
With Different Oral Toxicity Profiles.
Oncologist. 2024;29:e382-e391.
PLoS One
- AJENU EO, Seideneck AM, Pandellapalli E, Shinsky EM, et al
ABCG2 transporter reduces protein aggregation in cigarette smoke
condensate-exposed A549 lung cancer cells.
PLoS One. 2024;19:e0297661.
- KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016